US12459942B2ActiveUtilityA1
Inhibiting (α-v)(β-6) integrin
Est. expiryAug 29, 2038(~12.1 yrs left)· nominal 20-yr term from priority
Inventors:Bryce A. HarrisonJames E. DowlingMatthew G. BursavichDawn M. TroastBlaise S. LippaBruce N. RogersKristopher N. HahnCheng ZhongQi QiaoFu-Yang LinBrian SosaAleksey I. GerasyutoAndrea BortolatoMats A. SvenssonEugene Richard HickeyKyle D. KonzeTyler DayByungchan Kim
A61K 9/0053A61K 31/4375A61P 9/10A61P 35/00A61P 19/10A61P 27/02A61P 37/06A61P 29/00A61P 43/00C07D 471/04
85
PatentIndex Score
0
Cited by
233
References
18
Claims
Abstract
Disclosed are small molecule inhibitors of αvβ6 integrin, and methods of using them to treat a number of diseases and conditions.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A compound selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 , having the formula:
or a pharmaceutically acceptable salt thereof.
3. The compound of claim 1 , having the formula:
or a pharmaceutically acceptable salt thereof.
4. The compound of claim 1 , having the formula:
or a pharmaceutically acceptable salt thereof.
5. The compound of claim 1 , having the formula:
or a pharmaceutically acceptable salt thereof.
6. The compound of claim 1 , having the formula:
or a pharmaceutically acceptable salt thereof.
7. The compound of claim 1 , wherein the compound is selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.
8. A compound selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.
9. The compound of claim 8 , wherein the compound is selected from the group consisting
or a pharmaceutically acceptable salt thereof.
10. The compound of claim 8 selected from the group consisting of
or a pharmaceutically acceptable salt thereof.
11. The compound of claim 8 selected from the group consisting of
or a pharmaceutically acceptable salt thereof.
12. A compound selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.
13. The compound of claim 12 selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.
14. The compound of claim 12 selected from the group consisting of
or a pharmaceutically acceptable salt thereof.
15. The compound of claim 12 selected from the group consisting of
or a pharmaceutically acceptable salt thereof.
16. A pharmaceutical composition, comprising the compound of claim 1 , or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.
17. A pharmaceutical composition, comprising the compound of claim 8 , or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.
18. A pharmaceutical composition, comprising the compound of claim 12 , or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.